Table 1.
Cell density in the PVN
| Cell profile | CSF-Control | CSF-Stress | Oxt-Control | Oxt-Stress | P-values |
|---|---|---|---|---|---|
| Fos-ir 3 | 7.33 ± 4.29 | 23.10 ± 4.29 | 5.92 ± 3.92 | 6.21 ± 3.63 = | 0.07 2 |
| AVP-ir 3 | 19.59 ± 3.23 | 16.83 ± 3.23 | 16.94 ±2.95 | 16.96 ± 2.73 | NS |
| Fos/AVP-ir 4 | 8.64 ± 4.05 | 14.57 ± 4.05 | 3.01 ± 3.70 | 5.59 ± 3.42 | NS |
| Oxt-ir 3 | 6.69 ± 5.75 | 11.49 ± 5.75 | 11.76 ± 5.25 | 16.28 ± 4.86 | NS |
| Fos/ Oxt-ir 4 | 6.83 ± 4.08 | 13.48 ± 4.07 | 8.47 ± 3.72 | 9.34 ± 3.45 | NS |
| CRH-ir 3 | 43.17 ± 7.25 | 33.165 ± 7.28 | 37.13 ± 6.62 | 36.48 ± 6.13 | NS |
| Fos/CRH-ir 4 | 1.95 ± 1.44a | 14.66 ± 1.44b | 3.05 ± 1.31a | 1.78 ± 1.22a | < 0.01 2 |
| GABA-ir 3 | 93.86 ± 18.68 | 64.92 ± 18.68 | 96.94 ± 17.05 | 82.63 ± 15.78 | NS |
| Fos/GABA-ir 4 | 0.57 ± 1.39 | 1.88 ± 1.39 | 4.30 ± 1.27 | 4.175 ± 1.17 | < 0.05 1 |
Note. Immunoreactive = ir; vasopressin = AVP; oxytocin = Oxt; corticotrophin-releasing hormone = CRH; gamma-aminobutyric acid = GABA;
P-values reflect significant main effect of Oxt treatment1, significant interaction between stress and Oxt treatment2, or no significant effect of either stress or Oxt treatment (NS) as determined by a two-way ANOVA. Units are reported as number of neurons (per 0.1 mm2)3 or percentage of neurons expressing c-Fos4.
Letters indicate significant group differences.